Reproductive Justice, Health & Rights

Advocates for reproductive health, rights, and justice are increasingly aware of the safety and social risks of assisted reproductive technologies and other human biotechnologies, particularly for women and children.

While assisted reproduction has helped many people create families, the long-term risks of these technologies – particularly those that require egg provision – are grossly understudied. In the U.S., assisted reproduction has developed almost entirely in the commercial sector and is notoriously underregulated. 

Heritable genome editing, if allowed, would develop in this same commercial sector. Reproductive justice advocates draw attention to the risks to women and children’s health and wellbeing, the historical context of population control and reproductive oppression, and the likelihood that it would exacerbate reproductive, racial, and disability injustice.

Biopolitical Times
New materials from CGS and Black Women for Wellness put the development of germline modification within the context of historical attempts to control the reproductive lives of women, trans, and nonbinary people.
Biopolitical Times
On June 13, the Center for Genetics and Society, alongside Black Women for Wellness and In Our Own Voice National Black Women’s Reproductive Justice Agenda, will be hosting the webinar, “Gene Editing and the Future of Reproductive Justice.”...

Aggregated News

Medical researchers would be allowed to buy women’s eggs under a bill being considered by the Legislature this week. As pro-choice, feminist scholars, we are deeply troubled by this legislation.
Biopolitical Times

Photo from Belly of the Beast, used by permission

Yesterday, California became the third state in the nation to...

Biopolitical Times
Biopolitical Times

Aggregated News

Aggregated News

Biopolitical Times

Unraveling the Fertility Industry: Challenges and Strategies for Movement Building

Submitted by admin on

Unraveling the Fertility Industry: Challenges and Strategies for Movement Building 

An international consultation hosted by Sama Resource Group for Women and Health in New Delhi between 22 and 24 January 2010

In a time when tissues, gametes, technologies, as well as the people who seek these technologies, are crossing borders, concerns about the commercial, economic and ethical aspects of assisted reproductive technologies go beyond national or even regional boundaries. This consultation aimed to bring together a balanced representation of activists, scholars and researchers from different movements, networks, and organisations from across the world working on similar concerns.

Sama Resource Group for Women and Health published a report [PDF] on the consultation, which includes a summary of Marcy Darnovsky's presentation, "Commercialisation of Reproductive and Genetic Technologies: What Lessons for Biotech Developments around the Globe?"

 

 

Is Op-Ed
Off
Category
Date
2010-01-22T12:00:00
Biopolitical Times
Biopolitical Times